Pharmacokinetic and Pharmacodynamics Studies of Nicotine After Oral Administration in Mice: Effects of Methoxsalen, a CYP2A5/6 Inhibitor

Comparison of nicotine oral consumption and baseline anxiety measures in adolescent and adult C57BL/6J and C3H/Ibg mice

(2012) Jennifer A. Wilking et al.   BEHAVIOURAL BRAIN RESEARCH

Adult mice voluntarily progress to nicotine dependence in an oral self-selection assay

(2012) Laura L. Locklear et al.   NEUROPHARMACOLOGY

Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended-Duration Transdermal Nicotine Therapy

(2010) C Lerman et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers

(2009) MK Ho et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Editorial:DrosophilaNeurogenetics - The Heisenberg Impact

(2009) Erich Buchner et al.   JOURNAL OF NEUROGENETICS

Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo-controlled Trial of Bupropion

(2008) F Patterson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Novel Pharmacological Approaches for Treating Tobacco Dependence and Withdrawal

(2008) August R Buchhalter et al.   DRUGS